Cargando…
Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway
Tubulointerstitial inflammation is crucial for the progression of diabetic nephropathy (DN), and tubular cells act as a driving force in the inflammatory cascade. Emerging data suggested that tacrolimus (TAC) ameliorates podocyte injury and macrophage infiltration in streptozotocin (STZ) mice. Howev...
Autores principales: | Zhang, Shumin, Wang, Huafen, Liu, Yifei, Yang, Wenxia, Liu, Jialu, Han, Yuzhang, Liu, Yu, Liu, Fuyou, Sun, Lin, Xiao, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520323/ https://www.ncbi.nlm.nih.gov/pubmed/32779844 http://dx.doi.org/10.1111/jcmm.15562 |
Ejemplares similares
-
Identification of transcription factors related to diabetic tubulointerstitial injury
por: Liu, Jialu, et al.
Publicado: (2023) -
ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response
por: Liu, Yifei, et al.
Publicado: (2023) -
Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy
por: Ma, Ruixia, et al.
Publicado: (2021) -
Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy
por: Yao, Xingmei, et al.
Publicado: (2022) -
Tubulointerstitial disease in diabetic nephropathy
por: Tonolo, Giancarlo, et al.
Publicado: (2014)